NO20072642L - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Info

Publication number: NO20072642L
Authority: NO; Norway
Prior art keywords: likelihood; acquiring; loss; androgens; reduce
Prior art date: 2004-11-01

Application number

NO20072642A

Other languages

English (en)

Norwegian (no)

Inventor

Fernand Labrie

Mohamed El-Alfy

Lamia Azzi

Original Assignee

Endorech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-01

Filing date

2007-05-23

Publication date

2007-07-30

2007-05-23 Application filed by Endorech Inc filed Critical Endorech Inc

2007-07-30 Publication of NO20072642L publication Critical patent/NO20072642L/no

Links

239000003098 androgen Substances 0.000 title abstract 2
229940030486 androgens Drugs 0.000 title 1
230000009759 skin aging Effects 0.000 title 1
206010002261 Androgen deficiency Diseases 0.000 abstract 1
208000035484 Cellulite Diseases 0.000 abstract 1
102000008186 Collagen Human genes 0.000 abstract 1
108010035532 Collagen Proteins 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010049752 Peau d'orange Diseases 0.000 abstract 1
206010040799 Skin atrophy Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000036232 cellulite Effects 0.000 abstract 1
229920001436 collagen Polymers 0.000 abstract 1
210000002808 connective tissue Anatomy 0.000 abstract 1
210000004177 elastic tissue Anatomy 0.000 abstract 1
239000003163 gonadal steroid hormone Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
230000037373 wrinkle formation Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Gerontology & Geriatric Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Birds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

NO20072642A 2004-11-01 2007-05-23 Use of androgens to reduce the likelihood of acquiring or to treat skin aging NO20072642L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62411204P	2004-11-01	2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en)	2004-11-01	2005-10-31	Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number	Publication Date
NO20072642L true NO20072642L (no)	2007-07-30

Family

ID=36318842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072642A NO20072642L (no)	2004-11-01	2007-05-23	Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Country Status (20)

Country	Link
US (1)	US20060178352A1 (sr)
EP (1)	EP1807062A4 (sr)
JP (1)	JP2008517952A (sr)
KR (1)	KR20070073964A (sr)
CN (1)	CN101094676A (sr)
AP (1)	AP2007003982A0 (sr)
AU (1)	AU2005301035A1 (sr)
BR (1)	BRPI0517950A (sr)
CA (1)	CA2585666A1 (sr)
EA (1)	EA200700983A1 (sr)
GE (1)	GEP20094833B (sr)
HR (1)	HRP20070183A2 (sr)
IL (1)	IL182844A0 (sr)
MA (1)	MA29220B1 (sr)
MX (1)	MX2007005098A (sr)
NO (1)	NO20072642L (sr)
RS (1)	RS20070185A (sr)
TN (1)	TNSN07163A1 (sr)
WO (1)	WO2006047859A1 (sr)
ZA (1)	ZA200703531B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106038572A (zh)	2004-10-20	2016-10-26	恩多研究公司	性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
US8269380B2 (en)	2006-06-01	2012-09-18	Panasonic Corporation	Brushless motor for washing machine having stress reduction on sensor casing and washing machine having the brushless motor mounted therein
US8268806B2 (en)	2007-08-10	2012-09-18	Endorecherche, Inc.	Pharmaceutical compositions
WO2015055179A1 (de) *	2013-10-15	2015-04-23	Chelac Holding Gmbh	Steroid-carbonsäureester, zusammensetzungen, enthaltend steroid-carbonsäureester und verwendung dieser bei lokal topischer applikation für kosmetische oder dermatologische zwecke
CN107949389A (zh) *	2015-09-30	2018-04-20	富士胶片株式会社	经皮吸收用组合物
JP2022548314A (ja) *	2019-09-23	2022-11-17	ザボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティー	妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法
US12426782B2 (en)	2020-11-06	2025-09-30	The Board Of Trustees Of The Leland Stanford Junior University	Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE531437A (sr) *	1953-08-26
PT1382340E (pt) *	1993-01-19	2006-07-31	Endorech Inc	Utilizacoes terapeuticas de desidroepiandrosterona para tratar libido diminuida e osteoporose
FR2729854A1 (fr) *	1995-01-26	1996-08-02	Oreal	Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) *	1995-09-12	1998-04-07	Estee Lauder, Inc.	Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) *	1996-08-02	1998-01-20	Rosenbaum; Jerry	Transdermal delivery of dehydroepiandrosterone
US5869090A (en) *	1998-01-20	1999-02-09	Rosenbaum; Jerry	Transdermal delivery of dehydroepiandrosterone
NZ536787A (en) *	1998-06-11	2006-03-31	Endorech Inc	Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
US6117446A (en) *	1999-01-26	2000-09-12	Place; Virgil A.	Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) *	2000-01-17	2004-04-02	Assist Publ Hopitaux De Paris	Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) *	2003-03-11	2004-10-07	Carrara Dario Norberto R.	Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) *	2001-06-27	2003-02-06	Van Der Hoop Roland Gerritsen	Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) *	2002-03-11	2004-01-08	Takeda Chem Ind Ltd	性ホルモン依存性疾患治療剤
IL157535A0 (en) *	2003-08-21	2004-03-28	Topimed Ltd	Preparations for the prevention of skin atrophy

2005
- 2005-10-31 HR HR20070183A patent/HRP20070183A2/xx not_active Application Discontinuation
- 2005-10-31 GE GEAP200510104A patent/GEP20094833B/en unknown
- 2005-10-31 BR BRPI0517950-5A patent/BRPI0517950A/pt not_active IP Right Cessation
- 2005-10-31 AP AP2007003982A patent/AP2007003982A0/xx unknown
- 2005-10-31 JP JP2007538225A patent/JP2008517952A/ja active Pending
- 2005-10-31 EA EA200700983A patent/EA200700983A1/ru unknown
- 2005-10-31 MX MX2007005098A patent/MX2007005098A/es not_active Application Discontinuation
- 2005-10-31 CA CA002585666A patent/CA2585666A1/en not_active Abandoned
- 2005-10-31 WO PCT/CA2005/001652 patent/WO2006047859A1/en not_active Ceased
- 2005-10-31 CN CNA2005800456687A patent/CN101094676A/zh active Pending
- 2005-10-31 RS RSP-2007/0185A patent/RS20070185A/sr unknown
- 2005-10-31 EP EP05799216A patent/EP1807062A4/en not_active Withdrawn
- 2005-10-31 AU AU2005301035A patent/AU2005301035A1/en not_active Abandoned
- 2005-10-31 KR KR1020077012537A patent/KR20070073964A/ko not_active Ceased
- 2005-11-01 US US11/264,704 patent/US20060178352A1/en not_active Abandoned
2007
- 2007-04-27 TN TNP2007000163A patent/TNSN07163A1/fr unknown
- 2007-04-29 IL IL182844A patent/IL182844A0/en unknown
- 2007-04-30 ZA ZA200703531A patent/ZA200703531B/xx unknown
- 2007-05-23 NO NO20072642A patent/NO20072642L/no not_active Application Discontinuation
- 2007-05-30 MA MA29957A patent/MA29220B1/fr unknown

Also Published As

Publication number	Publication date
CN101094676A (zh)	2007-12-26
WO2006047859A1 (en)	2006-05-11
EP1807062A1 (en)	2007-07-18
AU2005301035A1 (en)	2006-05-11
EA200700983A1 (ru)	2008-04-28
KR20070073964A (ko)	2007-07-10
BRPI0517950A (pt)	2008-10-21
JP2008517952A (ja)	2008-05-29
MX2007005098A (es)	2008-01-16
RS20070185A (sr)	2008-09-29
HRP20070183A2 (en)	2007-08-31
AP2007003982A0 (en)	2007-06-30
TNSN07163A1 (en)	2008-11-21
IL182844A0 (en)	2007-09-20
GEP20094833B (en)	2009-11-25
MA29220B1 (fr)	2008-02-01
CA2585666A1 (en)	2006-05-11
EP1807062A4 (en)	2009-06-03
US20060178352A1 (en)	2006-08-10
ZA200703531B (en)	2008-07-30

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE489957T1 (de)	2010-12-15	Mittel zur behandlung von entzündlichen erkrankungen
TW200509956A (en)	2005-03-16	Compositions and methods for treatment of rosacea
DE60135755D1 (de)	2008-10-23	Verbindungen und methoden zur behandlung von hautverletzungen
WO2008070859A3 (en)	2008-07-31	Treatment of skin conditions by dickkopf1 (dkk1)
SG196769A1 (en)	2014-02-13	Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
ATE376446T1 (de)	2007-11-15	Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
EA202191211A1 (ru)	2021-09-15	Композиции и способы для обработки транзиторных биопленок
EA200870393A1 (ru)	2009-04-28	Новые композиции для нарушений волос и способ получения композиций
TNSN07163A1 (en)	2008-11-21	Use of androgens to reduce the likelihood of acquiring or to treat skin aging
EA201290698A1 (ru)	2013-02-28	Композиция, содержащая экстракт венериной мухоловки для косметической обработки
MX2007009368A (es)	2008-01-14	Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.
WO2007099398A3 (en)	2007-12-27	Methods and compositions for treatment of skin
GB0015682D0 (en)	2000-08-16	Sprayable wound care composition
AU2010300611A8 (en)	2015-06-18	Hematopoietic stem cells for use in the treatment of a kidney injury
DE602005026866D1 (de)	2011-04-21	Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
WO2016065688A1 (zh)	2016-05-06	一种能激活肌肤活力和抗衰老的精华液
DE502004008793D1 (sr)	2009-02-12
Lou et al.	2012	Analysis of the effectiveness of basic fibroblast growth factor treatment on traumatic perforation of the tympanic membrane at different time points
PT1631275E (pt)	2008-08-04	Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno
ATE553760T1 (de)	2012-05-15	Verwendung von alverin zur behandlung von hauterkrankungen
BRPI0512503A (pt)	2008-03-11	composição que compreende ácido lático e lactoferrina
AU2020327022A8 (en)	2022-06-30	Method of treating cancer
US10874883B2 (en)	2020-12-29	Product for treating the skin and mucous membranes, and relative method of preparation
BR0111900A (pt)	2003-05-13	Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
MXPA04011018A (es)	2005-01-25	Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.